Tag archive for ‘developed by ICMR & Bharat Biotech’
By editor3 On Thursday, March 4th, 2021

Phase 3 Clinical Trial of COVAXIN, developed by ICMR & Bharat Biotech, shows 81% efficacy

New Delhi, March 04, 2021. Phase 3 results of the COVAXIN, developed by Indian Council of Medical Research (ICMR)in partnership with Bharat BiotechInternational Limited (BBIL),has shown an interim vaccine efficacy More...

Live Updates COVID-19 CASES